Related Experiment Videos
Opportunities for nanotechnology-based innovation in tissue proteomics
David H Geho1, Nicholas Lahar, Mauro Ferrari
1FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. gehod@mail.nih.gov
Biomedical Microdevices
|September 21, 2004
Summary
This review covers mass spectrometry (MS)-based protein diagnostics and protein microarrays for tissue proteomics. It highlights current goals and proposes nanotechnology for advanced molecular diagnostics and therapeutics in medicine.
Area of Science:
- Proteomics
- Nanotechnology
- Clinical Medicine
Background:
- Tissue proteomics is crucial for understanding disease mechanisms.
- Current diagnostic and therapeutic approaches require enhancement.
- Mass spectrometry (MS)-based protein pattern diagnostics and protein microarrays are key methodologies.
Purpose of the Study:
- To review current methodologies in tissue proteomics.
- To outline the objectives in the field of tissue proteomics.
- To propose nanotechnology-based solutions for diagnostics and therapeutics.
Main Methods:
- Discussion of mass spectrometry (MS)-based protein pattern diagnostics.
- Review of protein microarray technologies.
- Exploration of nanotechnology applications in proteomics.
Main Results:
- Identified key methodologies in tissue proteomics.
- Outlined current research goals and challenges.
- Suggested future directions for nanotechnology integration.
Conclusions:
- Nanotechnology holds significant potential to advance molecular diagnostics.
- Enhanced tools are needed for developing molecularly based therapeutics.
- Integrating nanotechnology can improve clinical medicine through improved diagnostics and therapeutics.